Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MRNA | NASDAQ | USD | Real-time | |
MRNA | Mexico | MXN | Delayed | |
MRNA | Milan | EUR | Real-time | |
0QF | Frankfurt | EUR | Delayed | |
0QF | TradeGate | EUR | Delayed | |
0QF | Xetra | EUR | Delayed | |
MRNAm | Buenos Aires | ARS | Delayed | |
M1RN34 | B3 | BRL | Delayed | |
MRNA | Vienna | EUR | Real-time | |
MRNA_KZ | KASE | USD | Delayed | |
MRNA | Lima | USD | Delayed |
Moderna, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 2,811 million compared to USD 5,084 million a year ago. Net income was USD 217 million compared to USD 1,465 million a year ago. Basic earnings per share from continuing operations was USD 0.57 compared to USD 3.81 a year ago. Diluted earnings per share from continuing operations was USD 0.55 compared to USD 3.61 a year ago.For the full year, revenue was USD 6,848 million compared to USD 19,263 million a year ago. Net loss was USD 4,714 million compared to net income of USD 8,362 million a year ago. Basic loss per share from continuing operations was USD 12.33 compared to basic earnings per share from continuing operations of USD 21.26 a year ago. Diluted loss per share from continuing operations was USD 12.33 compared to diluted earnings per share from continuing operations of USD 20.12 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 2811 | 1831 | 344 | 1862 |
Gross Profit | 476 | -1570 | -1535 | -61 |
Operating Income | 6 | -2012 | -1867 | -366 |
Net Income | 217 | -3630 | -1380 | 79 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 18426 | 19450 | 21884 | 24125 |
Total Liabilities | 4572 | 5995 | 4935 | 5262 |
Total Equity | 13854 | 13455 | 16949 | 18863 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 622 | -1600 | -915 | -1225 |
Cash From Investing Activities | -538 | 789 | 1944 | 2011 |
Cash From Financing Activities | -109 | -58 | -668 | -542 |
Net Change in Cash | -25 | -869 | 361 | 244 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review